Ovarian Cancer Diagnostics Market Size, Share, & Trends Analysis Report By Diagnosis Type (Imaging, Blood Test), By Cancer Type (Epithelial Tumor, Stromal Cell Tumor), By End Use, By Region, And Segment Forecasts, 2019 - 2026
- Report ID: GVR-3-68038-421-5
- Number of Pages: 100
- Format: Electronic (PDF)
- Historical Range: 2015 - 2017
- Industry: Healthcare
Market Segmentation
- Ovarian Cancer Diagnostics Cancer Type Outlook (Revenue, USD Million, 2015 - 2026)
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Ovarian Cancer Diagnostics Diagnosis Type Outlook (Revenue, USD Million, 2015 - 2026)
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Ovarian Cancer Diagnostics End-use Outlook (Revenue, USD Million, 2015 - 2026)
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Ovarian Cancer Diagnostics Regional Outlook (Revenue, USD Million, USD Million, 2015 - 2026)
- North America
- North America Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- North America Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- North America Ovarian Cancer Diagnostics Market, by End-Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- The U.S.
- U.S. Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- U.S. Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- U.S. Ovarian Cancer Diagnostics Market, by End-Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- U.S. Ovarian Cancer Diagnostics Market, by Cancer Type
- Canada
- Canada Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Canada Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Canada Ovarian Cancer Diagnostics Market, by End-Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Canada Ovarian Cancer Diagnostics Market, by Cancer Type
- North America Ovarian Cancer Diagnostics Market, by Cancer Type
- Europe
- Europe Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Europe Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Europe Ovarian Cancer Diagnostics Market, by End-Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- U.K.
- U.K. Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- U.K. Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- U.K. Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- U.K. Ovarian Cancer Diagnostics Market, by Cancer Type
- Germany
- Germany Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Germany Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Germany Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Germany Ovarian Cancer Diagnostics Market, by Cancer Type
- Spain
- Spain Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Spain Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Spain Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Spain Ovarian Cancer Diagnostics Market, by Cancer Type
- France
- France Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- France Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- France Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- France Ovarian Cancer Diagnostics Market, by Cancer Type
- Italy
- Italy Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Italy Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Italy Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Italy Ovarian Cancer Diagnostics Market, by Cancer Type
- Europe Ovarian Cancer Diagnostics Market, by Cancer Type
- Asia Pacific
- Asia Pacific Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Asia Pacific Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Asia Pacific Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Japan
- Japan Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Japan Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Japan Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Japan Ovarian Cancer Diagnostics Market, by Cancer Type
- China
- China Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- China Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- China Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- China Ovarian Cancer Diagnostics Market, by Cancer Type
- India
- India Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- India Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- India Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- India Ovarian Cancer Diagnostics Market, by Cancer Type
- South Korea
- South Korea Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- South Korea Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- South Korea Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- South Korea Ovarian Cancer Diagnostics Market, by Cancer Type
- Australia
- Australia Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Australia Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Australia Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Australia Ovarian Cancer Diagnostics Market, by Cancer Type
- Asia Pacific Ovarian Cancer Diagnostics Market, by Cancer Type
- Latin America
- Latin America Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Latin America Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Latin America Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Brazil
- Brazil Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Brazil Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Brazil Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Brazil Ovarian Cancer Diagnostics Market, by Cancer Type
- Mexico
- Mexico Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Mexico Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Mexico Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Mexico Ovarian Cancer Diagnostics Market, by Cancer Type
- Argentina
- Argentina Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Argentina Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Argentina Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Argentina Ovarian Cancer Diagnostics Market, by Cancer Type
- Latin America Ovarian Cancer Diagnostics Market, by Cancer Type
- Middle East & Africa
- Middle East & Africa Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Middle East & Africa Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Middle East & Africa Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- South Africa
- South Africa Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- South Africa Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- South Africa Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- South Africa Ovarian Cancer Diagnostics Market, by Cancer Type
- Saudi Arabia
- Saudi Arabia Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- Saudi Arabia Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- Saudi Arabia Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- Saudi Arabia Ovarian Cancer Diagnostics Market, by Cancer Type
- UAE
- UAE Ovarian Cancer Diagnostics Market, by Cancer Type
- Epithelial Tumor
- Germ Cell Tumor
- Stromal Cell Tumor
- Others
- UAE Ovarian Cancer Diagnostics Market, by Diagnosis Type
- Imaging
- Ultrasound
- CT Scan
- MRI Scan
- PET Scan
- Others
- Blood Test
- CA125
- HER2
- BRCA
- CEA
- ER & PR
- KRAS Mutation
- Others
- Biopsy
- Others
- Imaging
- UAE Ovarian Cancer Diagnostics Market, by End Use
- Hospital Laboratories
- Cancer Diagnostic Centers
- Research Institutes
- Others
- UAE Ovarian Cancer Diagnostics Market, by Cancer Type
- Middle East & Africa Ovarian Cancer Diagnostics Market, by Cancer Type
- North America
Report content
Qualitative Analysis
- Industry overview
- Industry trends
- Market drivers and restraints
- Market size
- Growth prospects
- Porter’s analysis
- PESTEL analysis
- Key market opportunities prioritized
- Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments
Quantitative Analysis
- Market size, estimates, and forecast from 2015 to 2026
- Market estimates and forecast for product segments up to 2026
- Regional market size and forecast for product segments up to 2026
- Market estimates and forecast for application segments up to 2026
- Regional market size and forecast for application segments up to 2026
- Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
